Ben Askew, PhD

Ben Askew is Vice President of Research at SciFluor Life Sciences and brings more than 20 years of experience in senior research positions in the biotechnology and pharmaceutical industries. He has specialized in building high functioning medicinal chemistry organizations, defining early IP and long-term R&D strategy, and leading NCE discovery programs.

Carl P. Decicco, PhD

Carl is the Head of Discovery at BMS and is responsible for the discovery and advancement of drug candidates for clinical studies. He also has oversight of the Drug Safety Evaluation team that provides supporting studies for all levels of clinical investigation.

Percy Carter, MBA, PhD

Percy is the Head of Discovery, Chemistry and Molecular Technologies at BMS. He leads a team responsible for discovering drug candidates across therapeutic areas and molecular platforms. His role requires collaboration across teams in multiple sites, including in the U.S. and India, to discover clinical candidates.

Catherine D. Strader, PhD

Catherine Strader has more than 25 years of pharmaceutical R&D experience, with expertise ranging from the selection of molecular targets through clinical proof of concept. She has held executive leadership positions at both Merck and Schering-Plough, and has guided more than 50 compounds through drug discovery and development.